These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34118826)

  • 1. The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results.
    Singer LS; Feldman AZ; Buerki RA; Horbinski CM; Lukas RV; Stupp R
    Chin Clin Oncol; 2021 Aug; 10(4):38. PubMed ID: 34118826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
    Weller M; Reifenberger G
    Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.
    Michiwaki Y; Hata N; Mizoguchi M; Hiwatashi A; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Togao O; Suzuki SO; Yoshimoto K; Iwaki T; Iihara K
    Clin Neurol Neurosurg; 2019 Dec; 187():105556. PubMed ID: 31639630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
    BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
    Bai J; Varghese J; Jain R
    Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.
    Sasaki H; Yoshida K
    Neurol Med Chir (Tokyo); 2017 Dec; 57(12):658-666. PubMed ID: 28845038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic classification of gliomas.
    Perry A; Wesseling P
    Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.
    Scott CB; Nelson JS; Farnan NC; Curran WJ; Murray KJ; Fischbach AJ; Gaspar LE; Nelson DF
    Cancer; 1995 Jul; 76(2):307-13. PubMed ID: 8625107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiles of glioma.
    Brennan C
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):291-7. PubMed ID: 21465149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving toward molecular classification of diffuse gliomas in adults.
    Theeler BJ; Yung WK; Fuller GN; De Groot JF
    Neurology; 2012 Oct; 79(18):1917-26. PubMed ID: 23109653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical importance of molecular markers of adult diffuse glioma.
    Molinari E; Curran OE; Grant R
    Pract Neurol; 2019 Oct; 19(5):412-416. PubMed ID: 31175262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO 2016 Classification of gliomas.
    Wesseling P; Capper D
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of gliomas.
    Masui K; Mischel PS; Reifenberger G
    Handb Clin Neurol; 2016; 134():97-120. PubMed ID: 26948350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system.
    Jiang H; Cui Y; Wang J; Lin S
    Oncotarget; 2017 Mar; 8(12):20354-20361. PubMed ID: 27888628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
    Macaulay RJ
    Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
    Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.